News

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

The new office is located within the administration office pod near the hospital’s main entrance at 421 S. Maple St. in Garnett, Kansas.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

In the past, many women born with a heart condition were told they would not be able to birth children safely.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.

National Healthcare Decisions Day on April 16 provides an opportunity to talk with loved ones about end of life care.

An Australian shepherd/boxer mix, Molly is one of the pet therapy pooches that—along with her human, Alexis Martin—elevate spirits around Saint Luke’s Hospice House.